Toll-like receptor 9 activation enhances B cell activating factor and interleukin-21 induced anti-proteinase 3 autoantibody production in vitro. 2016

Nikola Lepse, and Judith Land, and Abraham Rutgers, and Cees G M Kallenberg, and Coen A Stegeman, and Wayel H Abdulahad, and Peter Heeringa
Department of Pathology and Medical Biology, p.heeringa@umcg.nl.

OBJECTIVE Granulomatosis with polyangiitis (GPA) is a relapsing small-vessel vasculitis characterized by circulating ANCA against PR3. The mechanisms that trigger PR3-ANCA production are unknown. The aim of this study was to determine whether endogenous factors [B cell activating factor (BAFF) and IL-21] and exogenous factors [oligodeoxynucleotides containing CpG motifs (CpG-ODN)] synergize in stimulating PR3-ANCA production in GPA patients. METHODS Peripheral blood mononuclear cells from GPA patients and healthy controls (HCs) were cultured in the presence of BAFF and IL-21, with or without CpG-ODN, for 12 days. PR3-ANCA production in culture supernatants was quantified by Phadia EliA. Phenotypic characterization and the influence of CpG-ODN treatment on IL-21 receptor (IL-21R), transmembrane activator and calcium-modulator and cyclophilin ligand interactor (TACI) and BAFF receptor (BAFF-R) expression on B cells was analysed by flow cytometry. RESULTS Stimulation with BAFF and IL-21 significantly increased ANCA production in patient samples, which could be augmented further by addition of CpG-ODN. Stimulation with CpG-ODN increased the percentage of IL-21R(+) and TACI(+) B cells but did not affect BAFF-R expression. GPA patients had an increased percentage of circulating IL-21R(+) and a decreased percentage of TACI(+) circulating memory B cells when compared with HCs. Additionally, patients had decreased expression of BAFF-R on B cells, which was inversely correlated with BAFF concentrations in plasma. CONCLUSIONS Our data demonstrate that endogenous and exogenous factors can synergize to promote PR3-ANCA production. Mechanistically, CpG-ODN up-regulated IL-21R and TACI expression on B cells, possibly sensitizing these cells for IL-21- and BAFF-mediated signals. Agents inhibiting Toll-like receptor 9, BAFF and IL-21 signalling pathways may serve as potential therapeutics for intervention in GPA patients.

UI MeSH Term Description Entries
D007378 Interleukins Soluble factors which stimulate growth-related activities of leukocytes as well as other cell types. They enhance cell proliferation and differentiation, DNA synthesis, secretion of other biologically active molecules and responses to immune and inflammatory stimuli. Interleukin
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Nikola Lepse, and Judith Land, and Abraham Rutgers, and Cees G M Kallenberg, and Coen A Stegeman, and Wayel H Abdulahad, and Peter Heeringa
July 2005, The Journal of experimental medicine,
Nikola Lepse, and Judith Land, and Abraham Rutgers, and Cees G M Kallenberg, and Coen A Stegeman, and Wayel H Abdulahad, and Peter Heeringa
January 2020, Journal of innate immunity,
Nikola Lepse, and Judith Land, and Abraham Rutgers, and Cees G M Kallenberg, and Coen A Stegeman, and Wayel H Abdulahad, and Peter Heeringa
January 2023, International journal of molecular sciences,
Nikola Lepse, and Judith Land, and Abraham Rutgers, and Cees G M Kallenberg, and Coen A Stegeman, and Wayel H Abdulahad, and Peter Heeringa
December 2018, Journal of immunology (Baltimore, Md. : 1950),
Nikola Lepse, and Judith Land, and Abraham Rutgers, and Cees G M Kallenberg, and Coen A Stegeman, and Wayel H Abdulahad, and Peter Heeringa
December 2018, Clinical immunology (Orlando, Fla.),
Nikola Lepse, and Judith Land, and Abraham Rutgers, and Cees G M Kallenberg, and Coen A Stegeman, and Wayel H Abdulahad, and Peter Heeringa
October 2012, Scandinavian journal of immunology,
Nikola Lepse, and Judith Land, and Abraham Rutgers, and Cees G M Kallenberg, and Coen A Stegeman, and Wayel H Abdulahad, and Peter Heeringa
October 2011, Experimental cell research,
Nikola Lepse, and Judith Land, and Abraham Rutgers, and Cees G M Kallenberg, and Coen A Stegeman, and Wayel H Abdulahad, and Peter Heeringa
January 2011, PloS one,
Nikola Lepse, and Judith Land, and Abraham Rutgers, and Cees G M Kallenberg, and Coen A Stegeman, and Wayel H Abdulahad, and Peter Heeringa
January 2013, Immunology letters,
Nikola Lepse, and Judith Land, and Abraham Rutgers, and Cees G M Kallenberg, and Coen A Stegeman, and Wayel H Abdulahad, and Peter Heeringa
January 2014, PloS one,
Copied contents to your clipboard!